Loading…

The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States

Understanding the prevalence and clinical presentation of coronavirus disease 2019 in pediatric patients can help healthcare providers and systems prepare and respond to this emerging pandemic. This was a retrospective case series of patients tested for severe acute respiratory syndrome coronavirus...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the Pediatric Infectious Diseases Society 2020-11, Vol.9 (5), p.523-529
Main Authors: Otto, William R, Geoghegan, Sarah, Posch, Leila C, Bell, Louis M, Coffin, Susan E, Sammons, Julia S, Harris, Rebecca M, Odom John, Audrey R, Luan, Xianqun, Gerber, Jeffrey S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c415t-b118e8a0d899e66033a96c729a34adb8602a9ca52132eed1b7373b13c74deac03
cites cdi_FETCH-LOGICAL-c415t-b118e8a0d899e66033a96c729a34adb8602a9ca52132eed1b7373b13c74deac03
container_end_page 529
container_issue 5
container_start_page 523
container_title Journal of the Pediatric Infectious Diseases Society
container_volume 9
creator Otto, William R
Geoghegan, Sarah
Posch, Leila C
Bell, Louis M
Coffin, Susan E
Sammons, Julia S
Harris, Rebecca M
Odom John, Audrey R
Luan, Xianqun
Gerber, Jeffrey S
description Understanding the prevalence and clinical presentation of coronavirus disease 2019 in pediatric patients can help healthcare providers and systems prepare and respond to this emerging pandemic. This was a retrospective case series of patients tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across a pediatric healthcare network, including clinical features and outcomes of those with positive test results. Of 7256 unique children tested for SARS-CoV-2, 424 (5.8%) tested positive. Patients aged 18-21 years had the highest test positive rate (11.2%), while those aged 1-5 years had the lowest (3.9%). By race, 10.6% (226/2132) of black children tested positive vs 3.3% (117/3592) of white children. By indication for testing, 21.1% (371/1756) of patients with reported exposures or clinical symptoms tested positive vs 3.8% (53/1410) of those undergoing preprocedural or preadmission testing. Of 424 patients who tested positive for SARS-CoV-2, 182 (42.9%) had no comorbidities, 87 (20.5%) had asthma, and 55 (13.0%) were obese. Overall, 52.1% had cough, 51.2% fever, and 14.6% shortness of breath. Seventy-seven (18.2%) SARS-CoV-2-positive patients were hospitalized, of whom 24 (31.2%) required respiratory support. SARS-CoV-2-targeted antiviral therapy was given to 9 patients, and immunomodulatory therapy to 18 patients. Twelve (2.8%) SARS-CoV-2-positive patients required mechanical ventilation, and 2 patients required extracorporeal membrane oxygenation. Two patients died. In this large cohort of pediatric patients tested for SARS-CoV-2, the rate of infection was low but varied by testing indication. The majority of cases were mild and few children had critical illness.
doi_str_mv 10.1093/jpids/piaa074
format article
fullrecord <record><control><sourceid>proquest_COVID</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7337783</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2415286618</sourcerecordid><originalsourceid>FETCH-LOGICAL-c415t-b118e8a0d899e66033a96c729a34adb8602a9ca52132eed1b7373b13c74deac03</originalsourceid><addsrcrecordid>eNpdkU1v1DAURS0EolXpki2yxIZNWn8ksbNBqkYtrVQBYtq19WK_6XhI4mA7g4ZfT4YOVcEbW3pHx_fpEvKWszPOGnm-Gb1L56MHYKp8QY4FK3WhBFMvn72PyGlKGzafuuKVLl-TIymqqhFaHJNfd2ukl7MGex-68LCjYUWXuMWI9MJOGek3TKOPkEPc0eVucDH0SBchhgG2Pk6JCuoHCvQrOg85ekuvEbq8tjArPmP-GeL3PZHnj-4Hn9HRZYaM6Q15tYIu4enhPiH3V5d3i-vi9sunm8XFbWFLXuWi5VyjBuZ002BdMymhqa0SDcgSXKtrJqCxUAkuBaLjrZJKtlxaVToEy-QJ-fjoHae2R2dxyBE6M0bfQ9yZAN78Oxn82jyErVFSKqXlLPhwEMTwY8KUTe-Txa6DAcOUjJhzCl3XXM_o-__QTZjiMK-3p2pZVorvExWPlI0hpYirpzCcmX2x5k-x5lDszL97vsET_bdG-RttaqIT</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2416345710</pqid></control><display><type>article</type><title>The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States</title><source>Coronavirus Research Database</source><creator>Otto, William R ; Geoghegan, Sarah ; Posch, Leila C ; Bell, Louis M ; Coffin, Susan E ; Sammons, Julia S ; Harris, Rebecca M ; Odom John, Audrey R ; Luan, Xianqun ; Gerber, Jeffrey S</creator><creatorcontrib>Otto, William R ; Geoghegan, Sarah ; Posch, Leila C ; Bell, Louis M ; Coffin, Susan E ; Sammons, Julia S ; Harris, Rebecca M ; Odom John, Audrey R ; Luan, Xianqun ; Gerber, Jeffrey S</creatorcontrib><description>Understanding the prevalence and clinical presentation of coronavirus disease 2019 in pediatric patients can help healthcare providers and systems prepare and respond to this emerging pandemic. This was a retrospective case series of patients tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across a pediatric healthcare network, including clinical features and outcomes of those with positive test results. Of 7256 unique children tested for SARS-CoV-2, 424 (5.8%) tested positive. Patients aged 18-21 years had the highest test positive rate (11.2%), while those aged 1-5 years had the lowest (3.9%). By race, 10.6% (226/2132) of black children tested positive vs 3.3% (117/3592) of white children. By indication for testing, 21.1% (371/1756) of patients with reported exposures or clinical symptoms tested positive vs 3.8% (53/1410) of those undergoing preprocedural or preadmission testing. Of 424 patients who tested positive for SARS-CoV-2, 182 (42.9%) had no comorbidities, 87 (20.5%) had asthma, and 55 (13.0%) were obese. Overall, 52.1% had cough, 51.2% fever, and 14.6% shortness of breath. Seventy-seven (18.2%) SARS-CoV-2-positive patients were hospitalized, of whom 24 (31.2%) required respiratory support. SARS-CoV-2-targeted antiviral therapy was given to 9 patients, and immunomodulatory therapy to 18 patients. Twelve (2.8%) SARS-CoV-2-positive patients required mechanical ventilation, and 2 patients required extracorporeal membrane oxygenation. Two patients died. In this large cohort of pediatric patients tested for SARS-CoV-2, the rate of infection was low but varied by testing indication. The majority of cases were mild and few children had critical illness.</description><identifier>ISSN: 2048-7207</identifier><identifier>ISSN: 2048-7193</identifier><identifier>EISSN: 2048-7207</identifier><identifier>DOI: 10.1093/jpids/piaa074</identifier><identifier>PMID: 32559282</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adolescent ; Asymptomatic Diseases ; Betacoronavirus ; Child ; Child, Preschool ; Clinical Laboratory Techniques ; Coronavirus Infections - complications ; Coronavirus Infections - diagnosis ; Coronavirus Infections - epidemiology ; Coronavirus Infections - mortality ; COVID-19 ; COVID-19 Testing ; Female ; Hospitalization ; Humans ; Infant ; Male ; New Jersey - epidemiology ; Original ; Pandemics ; Pennsylvania - epidemiology ; Pneumonia, Viral - complications ; Pneumonia, Viral - diagnosis ; Pneumonia, Viral - epidemiology ; Pneumonia, Viral - mortality ; Polymerase Chain Reaction ; Retrospective Studies ; SARS-CoV-2</subject><ispartof>Journal of the Pediatric Infectious Diseases Society, 2020-11, Vol.9 (5), p.523-529</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.</rights><rights>2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://academic.oup.com/journals/pages/coronavirus .</rights><rights>The Author(s) 2020. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2020</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c415t-b118e8a0d899e66033a96c729a34adb8602a9ca52132eed1b7373b13c74deac03</citedby><cites>FETCH-LOGICAL-c415t-b118e8a0d899e66033a96c729a34adb8602a9ca52132eed1b7373b13c74deac03</cites><orcidid>0000-0001-7959-1445</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2416345710?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,38516,43895</link.rule.ids><linktorsrc>$$Uhttps://www.proquest.com/docview/2416345710?pq-origsite=primo$$EView_record_in_ProQuest$$FView_record_in_$$GProQuest</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32559282$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Otto, William R</creatorcontrib><creatorcontrib>Geoghegan, Sarah</creatorcontrib><creatorcontrib>Posch, Leila C</creatorcontrib><creatorcontrib>Bell, Louis M</creatorcontrib><creatorcontrib>Coffin, Susan E</creatorcontrib><creatorcontrib>Sammons, Julia S</creatorcontrib><creatorcontrib>Harris, Rebecca M</creatorcontrib><creatorcontrib>Odom John, Audrey R</creatorcontrib><creatorcontrib>Luan, Xianqun</creatorcontrib><creatorcontrib>Gerber, Jeffrey S</creatorcontrib><title>The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States</title><title>Journal of the Pediatric Infectious Diseases Society</title><addtitle>J Pediatric Infect Dis Soc</addtitle><description>Understanding the prevalence and clinical presentation of coronavirus disease 2019 in pediatric patients can help healthcare providers and systems prepare and respond to this emerging pandemic. This was a retrospective case series of patients tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across a pediatric healthcare network, including clinical features and outcomes of those with positive test results. Of 7256 unique children tested for SARS-CoV-2, 424 (5.8%) tested positive. Patients aged 18-21 years had the highest test positive rate (11.2%), while those aged 1-5 years had the lowest (3.9%). By race, 10.6% (226/2132) of black children tested positive vs 3.3% (117/3592) of white children. By indication for testing, 21.1% (371/1756) of patients with reported exposures or clinical symptoms tested positive vs 3.8% (53/1410) of those undergoing preprocedural or preadmission testing. Of 424 patients who tested positive for SARS-CoV-2, 182 (42.9%) had no comorbidities, 87 (20.5%) had asthma, and 55 (13.0%) were obese. Overall, 52.1% had cough, 51.2% fever, and 14.6% shortness of breath. Seventy-seven (18.2%) SARS-CoV-2-positive patients were hospitalized, of whom 24 (31.2%) required respiratory support. SARS-CoV-2-targeted antiviral therapy was given to 9 patients, and immunomodulatory therapy to 18 patients. Twelve (2.8%) SARS-CoV-2-positive patients required mechanical ventilation, and 2 patients required extracorporeal membrane oxygenation. Two patients died. In this large cohort of pediatric patients tested for SARS-CoV-2, the rate of infection was low but varied by testing indication. The majority of cases were mild and few children had critical illness.</description><subject>Adolescent</subject><subject>Asymptomatic Diseases</subject><subject>Betacoronavirus</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Clinical Laboratory Techniques</subject><subject>Coronavirus Infections - complications</subject><subject>Coronavirus Infections - diagnosis</subject><subject>Coronavirus Infections - epidemiology</subject><subject>Coronavirus Infections - mortality</subject><subject>COVID-19</subject><subject>COVID-19 Testing</subject><subject>Female</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Infant</subject><subject>Male</subject><subject>New Jersey - epidemiology</subject><subject>Original</subject><subject>Pandemics</subject><subject>Pennsylvania - epidemiology</subject><subject>Pneumonia, Viral - complications</subject><subject>Pneumonia, Viral - diagnosis</subject><subject>Pneumonia, Viral - epidemiology</subject><subject>Pneumonia, Viral - mortality</subject><subject>Polymerase Chain Reaction</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><issn>2048-7207</issn><issn>2048-7193</issn><issn>2048-7207</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><recordid>eNpdkU1v1DAURS0EolXpki2yxIZNWn8ksbNBqkYtrVQBYtq19WK_6XhI4mA7g4ZfT4YOVcEbW3pHx_fpEvKWszPOGnm-Gb1L56MHYKp8QY4FK3WhBFMvn72PyGlKGzafuuKVLl-TIymqqhFaHJNfd2ukl7MGex-68LCjYUWXuMWI9MJOGek3TKOPkEPc0eVucDH0SBchhgG2Pk6JCuoHCvQrOg85ekuvEbq8tjArPmP-GeL3PZHnj-4Hn9HRZYaM6Q15tYIu4enhPiH3V5d3i-vi9sunm8XFbWFLXuWi5VyjBuZ002BdMymhqa0SDcgSXKtrJqCxUAkuBaLjrZJKtlxaVToEy-QJ-fjoHae2R2dxyBE6M0bfQ9yZAN78Oxn82jyErVFSKqXlLPhwEMTwY8KUTe-Txa6DAcOUjJhzCl3XXM_o-__QTZjiMK-3p2pZVorvExWPlI0hpYirpzCcmX2x5k-x5lDszL97vsET_bdG-RttaqIT</recordid><startdate>20201110</startdate><enddate>20201110</enddate><creator>Otto, William R</creator><creator>Geoghegan, Sarah</creator><creator>Posch, Leila C</creator><creator>Bell, Louis M</creator><creator>Coffin, Susan E</creator><creator>Sammons, Julia S</creator><creator>Harris, Rebecca M</creator><creator>Odom John, Audrey R</creator><creator>Luan, Xianqun</creator><creator>Gerber, Jeffrey S</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>COVID</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7959-1445</orcidid></search><sort><creationdate>20201110</creationdate><title>The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States</title><author>Otto, William R ; Geoghegan, Sarah ; Posch, Leila C ; Bell, Louis M ; Coffin, Susan E ; Sammons, Julia S ; Harris, Rebecca M ; Odom John, Audrey R ; Luan, Xianqun ; Gerber, Jeffrey S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c415t-b118e8a0d899e66033a96c729a34adb8602a9ca52132eed1b7373b13c74deac03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adolescent</topic><topic>Asymptomatic Diseases</topic><topic>Betacoronavirus</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Clinical Laboratory Techniques</topic><topic>Coronavirus Infections - complications</topic><topic>Coronavirus Infections - diagnosis</topic><topic>Coronavirus Infections - epidemiology</topic><topic>Coronavirus Infections - mortality</topic><topic>COVID-19</topic><topic>COVID-19 Testing</topic><topic>Female</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Infant</topic><topic>Male</topic><topic>New Jersey - epidemiology</topic><topic>Original</topic><topic>Pandemics</topic><topic>Pennsylvania - epidemiology</topic><topic>Pneumonia, Viral - complications</topic><topic>Pneumonia, Viral - diagnosis</topic><topic>Pneumonia, Viral - epidemiology</topic><topic>Pneumonia, Viral - mortality</topic><topic>Polymerase Chain Reaction</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><toplevel>online_resources</toplevel><creatorcontrib>Otto, William R</creatorcontrib><creatorcontrib>Geoghegan, Sarah</creatorcontrib><creatorcontrib>Posch, Leila C</creatorcontrib><creatorcontrib>Bell, Louis M</creatorcontrib><creatorcontrib>Coffin, Susan E</creatorcontrib><creatorcontrib>Sammons, Julia S</creatorcontrib><creatorcontrib>Harris, Rebecca M</creatorcontrib><creatorcontrib>Odom John, Audrey R</creatorcontrib><creatorcontrib>Luan, Xianqun</creatorcontrib><creatorcontrib>Gerber, Jeffrey S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Coronavirus Research Database</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the Pediatric Infectious Diseases Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Otto, William R</au><au>Geoghegan, Sarah</au><au>Posch, Leila C</au><au>Bell, Louis M</au><au>Coffin, Susan E</au><au>Sammons, Julia S</au><au>Harris, Rebecca M</au><au>Odom John, Audrey R</au><au>Luan, Xianqun</au><au>Gerber, Jeffrey S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States</atitle><jtitle>Journal of the Pediatric Infectious Diseases Society</jtitle><addtitle>J Pediatric Infect Dis Soc</addtitle><date>2020-11-10</date><risdate>2020</risdate><volume>9</volume><issue>5</issue><spage>523</spage><epage>529</epage><pages>523-529</pages><issn>2048-7207</issn><issn>2048-7193</issn><eissn>2048-7207</eissn><abstract>Understanding the prevalence and clinical presentation of coronavirus disease 2019 in pediatric patients can help healthcare providers and systems prepare and respond to this emerging pandemic. This was a retrospective case series of patients tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) across a pediatric healthcare network, including clinical features and outcomes of those with positive test results. Of 7256 unique children tested for SARS-CoV-2, 424 (5.8%) tested positive. Patients aged 18-21 years had the highest test positive rate (11.2%), while those aged 1-5 years had the lowest (3.9%). By race, 10.6% (226/2132) of black children tested positive vs 3.3% (117/3592) of white children. By indication for testing, 21.1% (371/1756) of patients with reported exposures or clinical symptoms tested positive vs 3.8% (53/1410) of those undergoing preprocedural or preadmission testing. Of 424 patients who tested positive for SARS-CoV-2, 182 (42.9%) had no comorbidities, 87 (20.5%) had asthma, and 55 (13.0%) were obese. Overall, 52.1% had cough, 51.2% fever, and 14.6% shortness of breath. Seventy-seven (18.2%) SARS-CoV-2-positive patients were hospitalized, of whom 24 (31.2%) required respiratory support. SARS-CoV-2-targeted antiviral therapy was given to 9 patients, and immunomodulatory therapy to 18 patients. Twelve (2.8%) SARS-CoV-2-positive patients required mechanical ventilation, and 2 patients required extracorporeal membrane oxygenation. Two patients died. In this large cohort of pediatric patients tested for SARS-CoV-2, the rate of infection was low but varied by testing indication. The majority of cases were mild and few children had critical illness.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>32559282</pmid><doi>10.1093/jpids/piaa074</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0001-7959-1445</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier ISSN: 2048-7207
ispartof Journal of the Pediatric Infectious Diseases Society, 2020-11, Vol.9 (5), p.523-529
issn 2048-7207
2048-7193
2048-7207
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7337783
source Coronavirus Research Database
subjects Adolescent
Asymptomatic Diseases
Betacoronavirus
Child
Child, Preschool
Clinical Laboratory Techniques
Coronavirus Infections - complications
Coronavirus Infections - diagnosis
Coronavirus Infections - epidemiology
Coronavirus Infections - mortality
COVID-19
COVID-19 Testing
Female
Hospitalization
Humans
Infant
Male
New Jersey - epidemiology
Original
Pandemics
Pennsylvania - epidemiology
Pneumonia, Viral - complications
Pneumonia, Viral - diagnosis
Pneumonia, Viral - epidemiology
Pneumonia, Viral - mortality
Polymerase Chain Reaction
Retrospective Studies
SARS-CoV-2
title The Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a Pediatric Healthcare Network in the United States
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T12%3A08%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_COVID&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Epidemiology%20of%20Severe%20Acute%20Respiratory%20Syndrome%20Coronavirus%202%20in%20a%20Pediatric%20Healthcare%20Network%20in%20the%20United%20States&rft.jtitle=Journal%20of%20the%20Pediatric%20Infectious%20Diseases%20Society&rft.au=Otto,%20William%20R&rft.date=2020-11-10&rft.volume=9&rft.issue=5&rft.spage=523&rft.epage=529&rft.pages=523-529&rft.issn=2048-7207&rft.eissn=2048-7207&rft_id=info:doi/10.1093/jpids/piaa074&rft_dat=%3Cproquest_COVID%3E2415286618%3C/proquest_COVID%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c415t-b118e8a0d899e66033a96c729a34adb8602a9ca52132eed1b7373b13c74deac03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2416345710&rft_id=info:pmid/32559282&rfr_iscdi=true